Stem cell treatment to be used in premiere in Japan – The Tokyo Times
|
Stem cell treatment to be used in premiere in Japan
The Tokyo Times Japan will use for the first time a stem cell treatment owned by Mesoblast Pharmaceutical. The product will be launched on the market by JCR Pharmaceutical, a local partner. The treatment will be used for the so-called graft versus host disease (GVHD), … |
